崔巍.脉波指数连续心搏量监测在连续肾脏替代疗法治疗脓毒症并发急性呼吸窘迫综合征患者中的临床价值[J].内科急危重症杂志,2017,23(6):486-489
扫码阅读全文
|
| DOI：10.11768/nkjwzzzz20170613 |
| 中文关键词: 脓毒症 急性呼吸窘迫综合征 连续肾脏替代疗法 脉波指数连续心搏量 循环功能 呼吸功能 |
| 英文关键词: |
| 基金项目: |
|
| 摘要点击次数: 1641 |
| 全文下载次数: 2899 |
| 中文摘要: |
| 目的：探讨脉波指数连续心搏量（PICCO）监测对连续肾脏替代疗法（CRRT)治疗脓毒症并发急性呼吸窘迫综合征（ARDS）患者时临床参数调整的指导价值，寻找控制患者血容量更为精确的临床方法。方法：选择接受CRRT治疗的脓毒症并发ARDS患者84例，采用数字随机表法将其分为对照组和观察组，每组42例，对照组采用常规方法对患者的血容量进行调节，观察组患者采用PICCO监测心指数（CI）、舒张末期容积指数（EDVI）及胸腔血容积指数（ITBI）对血容量进行调节。比较2组患者入组前、入组后12、48、96h的炎症细胞因子（IL-6、IL-8、IL-1β、TNF-α）水平、呼吸功能指标\[呼吸频率、氧分压（PaO2）、氧合指数（PaO2／FiO2）、APACHEⅡ评分\]及循环功能指标（动脉收缩压、舒张压、心率），统计2组患者机械通气时间、住ICU时间及病死率。结果：2组患者入组前炎症细胞因子水平、呼吸功能及循环功能指标比较差异均无统计学意义（均P>0.05）；治疗后12、48、96h时，2组患者炎症细胞因子（IL-6、IL-8、IL-1β、TNF-α）水平均降低，但观察组患者在48、96h后均低于对照组（均P＜0.05）；治疗后12h2组患者的呼吸频率、APACHEⅡ评分均降低，PaO2、PaO2／FiO2均升高，但观察组呼吸频率、APACHEⅡ评分低于对照组，PaO2、PaO2／FiO2高于对照组（均P<0.05），继续治疗48、96h后变化不大。治疗后12、48、96h时2组患者的心率降低，动脉收缩压、舒张压升高，但观察组心率、动脉收缩压、舒张压均低于对照组（均P<0.05）。观察组住ICU时间、机械通气时间及病死率均低于对照组（均P<0.05）。结论：PICCO监测CRRT治疗脓毒症合并ARDS对患者呼吸、循环各指标控制效果更优，患者的预后明显优于常规控制手段，对脓毒症合并ARDS具有较高的临床价值。 |
| 英文摘要: |
| Objective: To investigate the guiding value of the adjustment of clinical parameters by pulseindex continuous cardiac output (PICCO) in continuous renal replacement therapy (CRRT) for sepsis complicated with acute respiratory distress syndrome (ARDS) in order to find a more accurate clinical method for controlling the volume of blood in patients. Methods: Eightyfour patients with sepsis and ARDS treated with CRRT were randomly divided into control group and observation group by digital random table method, 42 cases in each group. In the control group, the blood volume was adjusted by conventional methods, and that in the observation group was adjusted by monitoring cardiac index (CI), end diastolic volume index (GEDI) and intrathoracic blood volume index (ITBI) with PICCO. The levels of inflammatory cytokines (IL6, IL8, IL1beta, and TNFalpha), respiratory function indexes \[respiratory frequency, oxygen partial pressure (PaO2), oxygenation index (PaO2/FiO2), APACHE II score\] and circulatory function indexes (arterial systolic blood pressure, diastolic blood pressure, heart rate) were compared between two groups before, and 12h, 48h, 96h after enrollment. Mechanical ventilation time, ICU time and mortality were statistically analyzed in two groups. Results: There was no significant difference in inflammatory cytokine levels, respiratory function indexes and circulatory function indexes between two groups before enrollment (P>0.05). At 12h, 48h and 96h after treatment, inflammatory cytokines (IL6, IL8, IL1beta and TNFalpha) levels were significantly reduced, and those in the observation group at 48 h and 96 h after treatment were significantly lower than in the control group (P<0.05). At 12h after treatment, respiratory rate and APACHE score in two groups were decreased, and PaO2 and PaO2/FiO2 were increased. The respiratory frequency and APACHE score were lower, and PaO2 and PaO2/FiO2were higher than those in the control group (P<0.05). At 48h and 96h after treatment, there were no significant changes. After treatment, the heart rate was decreased, and arterial systolic and diastolic blood pressure in the two groups was increased; the heart rate, arterial systolic blood pressure and diastolic blood pressure in the observation group were lower than those in the control group (P<0.05). The ICU stay and the time of mechanical ventilation were shorter, and the mortality was lower in the observation group than those in the control group (P<0.05). Conclusion: PICCO monitoring in CRRT for sepsis complicated ARDS can more effectively control respiratory and circulatory indexes, and the prognosis of patients is significantly better than that of routine control. PICCO monitoring has high clinical value for sepsis complicated with ARDS. |
|
|
|
|
